Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-04

FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Carbidopa and Levodopa from Teva Pharmaceuticals USA, Inc., updating the product under the existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

SUPPL AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)